Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-ACE Oil by Trans-Catheter Arterial Embolization or ChemoEmbolization (TAE/TACE) in Patients With Hepatocellular Carcinoma
NCT05435014Phase 2Terminated
- Sponsor
- T-ACE Medical
- Start
- Sep 2022
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
A Phase 2 trial of ethiodized oil in hepatocellular carcinoma (HCC), sponsored by T-ACE Medical. Started Sep 2022; status: terminated.
02
Drugs
ethiodized oil
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT05435014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05435014.